Altfest L J & Co. Inc. Acquires 6,205 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Altfest L J & Co. Inc. lifted its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report) by 20.9% during the 4th quarter, Holdings Channel.com reports. The firm owned 35,886 shares of the exchange traded fund’s stock after purchasing an additional 6,205 shares during the period. Altfest L J & Co. Inc.’s holdings in SPDR S&P Biotech ETF were worth $3,204,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in XBI. Resources Management Corp CT ADV boosted its holdings in SPDR S&P Biotech ETF by 1,715.8% in the second quarter. Resources Management Corp CT ADV now owns 345 shares of the exchange traded fund’s stock valued at $29,000 after acquiring an additional 326 shares during the last quarter. Tyler Stone Wealth Management bought a new position in SPDR S&P Biotech ETF in the second quarter valued at about $33,000. EPG Wealth Management LLC boosted its holdings in SPDR S&P Biotech ETF by 152.7% in the third quarter. EPG Wealth Management LLC now owns 460 shares of the exchange traded fund’s stock valued at $34,000 after acquiring an additional 278 shares during the last quarter. Compass Wealth Management LLC bought a new position in SPDR S&P Biotech ETF in the fourth quarter valued at about $34,000. Finally, Fortis Capital Advisors LLC bought a new position in SPDR S&P Biotech ETF in the fourth quarter valued at about $38,000.

SPDR S&P Biotech ETF Trading Up 2.2 %

SPDR S&P Biotech ETF stock traded up $2.06 during mid-day trading on Wednesday, hitting $94.75. The stock had a trading volume of 6,144,737 shares, compared to its average volume of 11,686,499. The stock has a market capitalization of $7.27 billion, a PE ratio of 11.47 and a beta of 0.97. The stock has a 50-day simple moving average of $93.14 and a two-hundred day simple moving average of $82.48. SPDR S&P Biotech ETF has a 12 month low of $63.80 and a 12 month high of $103.52.

About SPDR S&P Biotech ETF

(Free Report)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

See Also

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.